As news has been publicised of the World Health Organisation validating the second China-produced vaccination, the CoronaVac vaccine developed by Chinese pharmaceutical company, Sinovac, for emergency use, news portal Xinhuanet has sought the insight of Prof. Neville Calleja on the matter.
The Head of the Department of Public Health within the Faculty of Medicine & Surgery at the University of Malta told journalists Chen Wenxian, Fu Yiming and Zuo Wei that the higher the trust in the vaccines available on the market, the quicker the world can advance to its goal of a high global protection against the COVID-19 pandemic.
“The quicker this is achieved, the less time available for the virus to mutate”, he continued.
The article which Prof. Calleja contributed to may be read in its entirety online.